US Patent 11065306 Methods for treating hypophosphatasia in children
Patent 11065306 was granted and assigned to Alexion Pharmaceuticals on July, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+313 characters)
Article
Patent abstract
The disclosure features methods for treating hypophosphatasia (HPP) in a patient (e.g., a child having HPP) exhibiting physical impairments, disability in activities of daily living (ADL), pain, and/or delayed motor development by administering a soluble alkaline phosphatase (sALP) to the patient.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Dawn Phillips0
Kenji Fujita0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Edits on 23 Apr, 2023
Golden AI
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110653060
Date of Patent
July 20, 2021
0Patent Application Number
160831860
Date Filed
September 1, 2016
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 13 Feb, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 11065306 Methods for treating hypophosphatasia in children
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11065306
Date of patent
July 20, 2021
Patent application number
16083186
Date Filed
September 1, 2016
Patent citations
Patent primary examiner
Find more entities like US Patent 11065306 Methods for treating hypophosphatasia in children
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
